The bad news: patients who were already taking metformin when diagnosed were more than twice as likely to
die than patients who never used the drug.
The research showed that NRSOT patients who experienced AKI - D during hospitalization were nearly three times [2.85] more likely to
die than patients who did not have AKI - D.
Not exact matches
The fictional
patients also
died three times more frequently
than the real
patients.
I do many things, administrative, worship planning, staff support,
patient and family care, but nothing is more sacred
than listening to and being with the
dying.
The bill allows «mentally competent»
patients with less
than 6 months to live to get prescription drugs that would speed up the
dying process, as long as two doctors agree the
patient qualifies.
The
patient died at the hospital less
than an hour after she arrived and her twins
died in her womb.
But he approves of it in the case of a physician who» knowingly facilitated» the suicide of a
patient whom he had treated for a long time, knew well, and who had convinced him early on that she preferred to
die rather
than go through a long and losing battle with cancer.
I saw more
than my share of
patients die for no reason in hospital during my career.
The essay «God as Monica's Breast» is worth the price of the volume, and the «Consenting to
Die» essay, which discusses suicide and death as something to do» rather
than just wait for, breaks into a fictional discussion between a doctor and a cancer
patient.
«Working with
dying patients over many years has made me much more religious
than I have ever been.»
When we LOOK at reality...... when we REALLY LOOK closely at who's life is snuffed from EXISTENCE...... MORE
PATIENTS DIE UNDER HOSPITAL CARE
than the non-professional quazie care.
Yes — some areas are in danger of losing primary emergency care, but in most areas of the state hospitals are beating each other over the head for
patients because there are more hospital rooms
than people
dying to get into them.
Low income heart
patients are more likely to
die after surgery
than those higher up the social scale, a report published by the British Medical Journal has found.
Macmillan's Cancer in the UK 2014 report shows that the majority (3 in every 4) of cancer
patients want to
die at home, but fewer
than a third are able to do so.
More
than 300 senior doctors have warned that
patients will
die while on waiting lists because of cuts to funding.
British
patients were found to be almost 50 per cent more likely to
die from poor care
than those in America.
In the U.S. alone, more
than 80,000 new melanoma cases are diagnosed each year and about 9,000 melanoma
patients die.
Among
patients with deadly cancers, more
than 90 percent
die because of metastatic spread of their disease.
Each year in the U.S., nearly 46,000 people are diagnosed with pancreatic cancer, and more
than 39,000
patients die, making it the fourth leading cause of cancer death.
More
than half of the
patients diagnosed with brain metastasis will
die within a few months.»
Overall,
patients with synucleinopathies
died about two years earlier
than participants without in the comparison group.
But for some
patients who have received therapy and survived, the risk of
dying from the side effects over the long term might be even higher
than from the cancer.
Many
patients with low - risk prostate cancer have a lower risk of
dying from prostate cancer
than from other causes.»
While the
patient eventually relapsed and
died more
than a year after CAR T - cell therapy, the brain tumor never recurred.
Moreover, the research shows, trauma
patients of all races are 40 percent less likely to
die — regardless of the severity of their injuries — if they are treated at hospitals with lower -
than - expected mortality rates, the vast majority of which serve predominantly white
patients.
The team found that obese people with kidney cancer had a 53 % lower risk of
dying from renal - cell carcinoma
than patients who were normal weight2.
Overall, most Asian subgroups were less likely to
die from cancer
than non-Hispanic white
patients.
When the condition is not responsive to high - dose vasopressors like norepinephrine and vasopressin, it is associated with high mortality, with more
than half of these
patients dying within 30 days,» Dr. Khanna said.
More
than twice as many untreated
patients died as those who received transfusions.
Of the five
patients who
died (19.2 % of those with neuroinvasive disease), all were older
than 70.
In more
than 20 percent of cases studied,
patients returned to the hospital within 30 days, and about five percent of
patients died within 30 days.
In 2013, more
than 10,000
patients died of AML.
By comparison, of more
than 1,000 relatives of Laron
patients who
died during the study, one in five succumbed to cancer.
More
than 200,000
patients in the United States
die annually of sepsis.
Professor Patrizio Lancellotti, chair of the ESC EACVI / HFA Cardiac Oncology Toxicity Registry, said: «
Patients with some forms of breast cancer are at greater risk of
dying from heart disease
than from cancer.
A few years ago he discovered that the average Academy Award winner lives four years longer
than other actors and that
patients admitted to a hospital over the weekend are 28 percent more likely to
die than those admitted on weekdays.
Mice bred to carry a gene variant found in a third of ALS
patients have a faster disease progression and
die sooner
than mice with the standard genetic model of the disease, according to Penn State College of Medicine researchers.
Public health researchers at Harvard found that elderly
patients were less likely to
die or be readmitted to the hospital within 30 days if treated by female doctors rather
than male.
One
patient who
died was taking 1400 milligrams of chlorpromazine a day — more
than four times the recommended dose.
The study drilled down in particular on
patients who had a high risk of
dying from a cause other
than prostate cancer within 10 years.
The results suggest that among
patients with no cardiac risk factors having noncardiac surgery, those
patients receiving β - blockers were 1.2 times more likely to
die than those not receiving β - blockers.
However, for
patients having noncardiac surgery with three to four cardiac risk factors, those receiving β - blockers were significantly less likely to
die than those not receiving β - blockers, the authors found.
A new population - based study has found that
patients with glioblastoma who
died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer
than patients who
died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer.
Patients in the study averaged three such shifts, which meant that their risk of dying increased by more than six percent compared with patients with access to fully staffed nursin
Patients in the study averaged three such shifts, which meant that their risk of
dying increased by more
than six percent compared with
patients with access to fully staffed nursin
patients with access to fully staffed nursing teams.
When a nursing home
patient is
dying, aggressive interventions such as inserting a feeding tube or sending the
patient to the emergency room can futilely exacerbate, rather
than relieve, their distress.
Forty - five percent of terminally ill
patients in the U.S. currently
die under hospice, and its use has grown by more
than 20 percent over the past decade.
When Lopes's group checked the
patients» medical histories, the researchers found that those with slowly activating channels were two times more likely
than patients with other mutations to
die before age 30 or develop serious symptoms such as fainting spells or heart attacks.
Patients receiving epinephrine in the later stages of resuscitation were more likely to
die than those who got their first epinephrine dose shortly after collapsing.
These added
patients, who did not receive interferon, more
than doubled their risk of
dying as a result of not being treated with the drug.
But
patients who had neurological infections had a higher risk of
dying of some other diseases
than the general population.